Mark S. Schroeder - 07 Feb 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, President-Diagnostics Lab
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol: LH
Transactions as of: 07 Feb 2023
Net transactions value: -$99,391
Form type: 4
Filing time: 09 Feb 2023, 08:04:51 UTC
Previous filing: 07 Feb 2023
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Sale	$99,391	-409	-5.8%	$243.01	6,687	07 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Restricted Stock Unit	Award	$0	+1,390	+81%	$0.000000	3,104	07 Feb 2023	Common Stock	1,390		Direct	F2, F3, F4
transaction	LH	Non-qualified Stock Options	Award	$0	+4,400		$0.000000	4,400	07 Feb 2023	Common Stock	4,400	$247.24	Direct	F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F3	The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.
F4	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F5	Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F6	The option vests in three equal annual installments beginning on the date reflected in this column.